Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,098.2 | 131.82 | 1,07,645.29 | 138.24 | 0.14 | 697.4 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,977 | 83.66 | 1,00,542.86 | 341.6 | 0.23 | 2,054.8 | 569.62 |
Fortis Healthcare Ltd FORTIS | 685.55 | 250.04 | 50,401.01 | 39.56 | 0.15 | 366.87 | 120.23 |
Narayana Hrudayalaya Ltd NH | 1,760.5 | 84.57 | 36,292.44 | 79.22 | 0.23 | 865.04 | 95.32 |
Global Health Ltd MEDANTA | 1,197.2 | 80.59 | 31,624.82 | 99.31 | 0 | 624.4 | 113.49 |
The purchase is anticipated to enhance Syngene's position in the biologics contract development and manufacturing organization (CDMO) arena, specifically in the US market.
The company reported an operating EBITDA of ₹343.60 Crore in the quarter four of FY25. It registered a growth of 8.4% on a year-on-year basis.
This acquisition will also augment Syngene’s biologics capabilities and further strengthen its global presence.
The company's revenue from operations also grew healthily, up by 10.6% YoY to ₹943 crore, as against ₹853.5 crore in Q3 FY24.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
